By Alexander Vassallo, Manager of Business Development West Coast (US), LSN

Digital RESI March provides valuable opportunities to partner with hundreds of active investors seeking early-stage assets in life science and healthcare, but equally valuable are the resources provided by key strategic partners providing the services necessary for business growth. Life Science Nation (LSN) is pleased to feature experienced industry professionals attending the March 22-24 Digital RESI partnering conference and hosting exciting workshops designed specifically to address the pain points of early-stage scientist-entrepreneurs raising their Seed to Series B funding rounds. Check out our workshops below and register to start booking meetings today!

Tuesday, March 22, 12 PM EDT

Keeping Your Life Science Startup Out of the ‘Valley of Death’
Instructor: Nishta Rao, MBA, Managing Director, Life Sciences, First Republic Bank
Moderated by First Republic Bank’s Nishta Rao, hear from CEOs and founders on their pain points and strategies on navigating their company out of the valley of death.

---

Tuesday, March 22, 1 PM EDT

Employee Risk Mitigation in Startups
Instructors:
Samuel Bilsky, Sales Consultant, TriNet
Anna Evans, Senior Consultant – Technology, TriNet
In the digital age, it’s important for entrepreneurs to prioritize their company’s most valuable asset: people. This session will detail how full-service HR can save precious time for entrepreneurs to focus on what matters while knowing their team is taken care of. In a sea of possibilities, understand your HR options, learn about PEO services, and how they can help scale your business with big-company benefits and infrastructure. There’s no one-size-fits all, so get tips on finding the right HR solution for your organization.

---

Wednesday, March 23, 12 PM EDT

Branding & Messaging: Seed to Series B
Instructors:
Claire (Chae-Kyeong) Jeong, VP of Investor Research, Asia Business Development, Life Science Nation
Candice He, VP of Business Development, Global Investment Strategist, Life Science Nation
To win capital, you must stand out from the crowd. The first way to do that is to have top-notch marketing collateral. This bootcamp discusses how to provide potential investors with high-quality, professional materials—materials that engage them, communicate your message clearly and concisely, and present the information they want to see in a way that helps them to decide quickly and easily if you are a potential fit for their needs.

---

Thursday, March 24, 12 PM EDT

Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?
Instructors:
Mark Mihanovic, Partner, McDermott Will & Emery
Aroma Sharma, Partner, McDermott Will & Emery
This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion.

By Joey Wong, Investor Research Analyst, Hong Kong BD, LSN

As Digital RESI, March 22-24 ramps up, so has interest from the RESI investor community. With over 300 investors already registered for the event, including large pharma/medtech, traditional VCs, family offices/private wealth, and angel groups, this virtual event is shaping up to be buzzing with activity and digital meetings.

What sets RESI apart from many partnering events is the Life Science Nation (LSN) dedicated Investor Research Team responsible for ensuring that each investor’s partnering profiles are comprehensive and up-to-date. This conference is an excellent opportunity for entrepreneurs and founders to expand their network in the industry and connect with investors and strategic partners that are a fit for their company. With less than two weeks left, the partnering activities are at their peak and there is no better time to reach out to investors and book meetings. Register now to connect with these investors at Digital RESI March:

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the LSN Partnering Conference Series

Part of the success of the Redefining Early Stage Investments (RESI) conference series over the past decade includes its flexible structure and ability to provide valuable partnering resources to early-stage companies and investors alike. While there is no substitute for in-person meetings, RESI’s virtual platform has provided attendees with ease of access around the world. This is why, moving into the new year, RESI will return with both virtual and in-person formats – providing attendees with options to fit their needs.

Digital RESI returns June 7-9 in a virtual format to provide a web-based partnering option to global attendees. RESI Boston will kick off the first in-person event September 20-22, 2022. There is no one-size-fits-all event structure that meets the needs and goals of fundraising executives, early-stage investors, and the many valuable service providers in life science and healthcare, but RESI provides options to attendees who do not need to sacrifice their goals and priorities in 2022 and keeps its promise to connect startups to the early-stage capital and channel partners they need.

By Rory McCann, Marketing Manager & Conference Producer, LSN

Life Science Nation is pleased to announce the preliminary lineup of speakers and presenters at Digital RESI March. It’s a priority that RESI represents many voices in early-stage fundraising and deal-making and includes the perspectives most valuable to founders seeking capital. The panels and voices behind the topics provide insight and add value to the challenging process of fundraising. Check out the preliminary lineup and learn more about panel topics! Do you have a story to add or a perspective to share? Let us know!

Featured Digital RESI March Panelists

Navid Alipour Managing Partner Analytics Ventures	Moshe Bellows General Partner Maccabee Ventures	Cynthia Cai Venture Partner Viva BioInnovator
Lana Caron Innovation Lead Philips Health Technology Ventures	David Crean President & CEO Coast BioVentures	Juan Cueva Director, New Ventures & Early Innovation Partnering Johnson & Johnson Innovation
Eric de la Fortelle Managing Partner Cathay Capital	Dipty Desai Co-Chair, TiE Global Health TiE Angels	Bettina Ernst Director BERNINA BioInvest
Isabel Fox General Partner Outsized Ventures	Scott Galasinski Global Head, BD, Licensing and Strategy, Biopharmaceuticals R&D AstraZeneca	Amit Garg Managing Partner Tau Ventures
Lana Ghanem Managing Director Hikma Ventures	Tali Hirsch Director, Venture Investments Fresenius Medical Care Ventures	Brenda Hogan Senior Investment Manager Ontario Capital Growth Corporation (OCGC)
Char Hu CEO The Helper Bees	Galym Imanbayev Partner Lightspeed Venture Partners	Seemant Jauhari Managing Partner HealthXCapital
Niall Kerrigan Program Manager Plug and Play Ventures	Megan Krench Director of Investments Sanofi Ventures	Yury Kukushkin Investment Director JDRF T1D Fund
Cynthia Lavoie President and Chief Investment Officer Centre for Commercialization of Regenerative Medicine (CCRM)	Linda Li Managing Director Vickers Venture Partners	Don Lin Co-Founder, Managing Director Guoqian Venture Capital Investment
Matt Martin Venture Partner Pathway Bioventures	Sara Núñez-Garcia Co-Founder & Partner Forty51 Ventures	Meredith Oppenheim Founder Vitality Society (Vitality Enterprises)
Raj Pallapothu Managing Director Bio 9 Ventures	Lise Pape Trustee Future Care Capital	Thea Pham Venture Fellow OCV Partners
Gayathri Radhakrishnan Senior Director Venture Capital – AI Fund Micron Ventures	Kyle Rand CEO Rendever	Nishta Rao Managing Director – Life Science First Republic Bank
Gita Reinitz Principal (NFX Bio) NFX	Rafael Rosengarten Co-Founder & CEO Genialis	Yaniv Sneor Founding Member Mid Atlantic Bio Angels
Catello Somma Senior Associate TVM Capital Life Science	Ramji Srinivasan Co-Founder & CEO Teiko.bio	Chelsea Sumner NALA Healthcare AI Startups Lead NVIDIA Inception Program
Davide Vigano Co-founder & CEO Sensoria Health	Scott Weiner Partner Amzak Health	Sa’ar Yaniv Director of Business Development Fortress Biotech
	Alicia Yin Vice President 6 Dimensions Capital